Skip to content

Kerr Douglas

Reporting owner on Forms 3, 4 and 5, CIK 1814189.

Kerr Douglas reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-16.

Issuers

IssuerRoles in the latest filingFilingsLast filed
DYN · Dyne Therapeutics, Inc.CIK 1818794officer (Head of R&D and CMO)22026-11-16

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
DYN · Dyne Therapeutics, Inc.Common Stock2026-11-13S sold-2,604$16.82167,960Form 4
DYN · Dyne Therapeutics, Inc.Common Stock2026-10-20A granted+8,000$0170,564Form 4
DYN · Dyne Therapeutics, Inc.Stock option (right to buy), derivative2026-10-20A granted+12,000$012,000Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001814189-26-000009 Dyne Therapeutics, Inc.2026-11-16
Form 4 0001814189-26-000007 Dyne Therapeutics, Inc.2026-10-22